FilingSEC EDGAR8-K
Curanex Pharmaceuticals Regains Compliance with Nasdaq Listing Rules
· SEC accepted
StageCompliance
Filing content
The company regained compliance with Nasdaq's minimum bid price requirement after maintaining a closing bid price of $1.00 or greater for ten consecutive business days.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…